Pacaud P - Search Results

1

Structure-activity relationships and structural conformation of a novel urotensin II-related peptide.

Chatenet D, Dubessy C, Leprince J, Boularan C, Carlier L, Ségalas-Milazzo I, Guilhaudis L, Oulyadi H, Davoust D, Scalbert E, Pfeiffer B, Renard P, Tonon MC, Lihrmann I, Pacaud P, Vaudry H. Chatenet D, et al. Among authors: pacaud p. Peptides. 2004 Oct;25(10):1819-30. doi: 10.1016/j.peptides.2004.04.019. Peptides. 2004. PMID: 15476952

2

Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction.

Labarrère P, Chatenet D, Leprince J, Marionneau C, Loirand G, Tonon MC, Dubessy C, Scalbert E, Pfeiffer B, Renard P, Calas B, Pacaud P, Vaudry H. Labarrère P, et al. Among authors: pacaud p. J Enzyme Inhib Med Chem. 2003 Apr;18(2):77-88. doi: 10.1080/1475636031000093507. J Enzyme Inhib Med Chem. 2003. PMID: 12943190

3

Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.

Chatenet D, Dubessy C, Boularan C, Scalbert E, Pfeiffer B, Renard P, Lihrmann I, Pacaud P, Tonon MC, Vaudry H, Leprince J. Chatenet D, et al. Among authors: pacaud p. J Med Chem. 2006 Nov 30;49(24):7234-8. doi: 10.1021/jm0602110. J Med Chem. 2006. PMID: 17125276

4

Structure-activity relationships of urotensin II and URP.

Leprince J, Chatenet D, Dubessy C, Fournier A, Pfeiffer B, Scalbert E, Renard P, Pacaud P, Oulyadi H, Ségalas-Milazzo I, Guilhaudis L, Davoust D, Tonon MC, Vaudry H. Leprince J, et al. Among authors: pacaud p. Peptides. 2008 May;29(5):658-73. doi: 10.1016/j.peptides.2007.08.014. Epub 2007 Aug 19. Peptides. 2008. PMID: 17931747 Review.

5

Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase.

Sauzeau V, Le Mellionnec E, Bertoglio J, Scalbert E, Pacaud P, Loirand G. Sauzeau V, et al. Among authors: pacaud p. Circ Res. 2001 Jun 8;88(11):1102-4. doi: 10.1161/hh1101.092034. Circ Res. 2001. PMID: 11397774

6

Urotensin II and atherosclerosis.

Loirand G, Rolli-Derkinderen M, Pacaud P. Loirand G, et al. Among authors: pacaud p. Peptides. 2008 May;29(5):778-82. doi: 10.1016/j.peptides.2007.08.024. Epub 2007 Sep 2. Peptides. 2008. PMID: 17933432 Review.

7

Rho exchange factors in the cardiovascular system.

Loirand G, Scalbert E, Bril A, Pacaud P. Loirand G, et al. Among authors: pacaud p. Curr Opin Pharmacol. 2008 Apr;8(2):174-80. doi: 10.1016/j.coph.2007.12.006. Epub 2008 Jan 28. Curr Opin Pharmacol. 2008. PMID: 18222728 Review.

8

Rho-kinase inhibitors: pharmacomodulations on the lead compound Y-32885.

Logé C, Wallez V, Scalbert E, Cario-Tourmaniantz C, Loirand G, Pacaud P, Lesieur D. Logé C, et al. Among authors: pacaud p. J Enzyme Inhib Med Chem. 2002 Dec;17(6):381-90. doi: 10.1080/1475636021000005659. J Enzyme Inhib Med Chem. 2002. PMID: 12683673

9

Stent implantation activates RhoA in human arteries: inhibitory effect of rapamycin.

Guérin P, Sauzeau V, Rolli-Derkinderen M, Al Habbash O, Scalbert E, Crochet D, Pacaud P, Loirand G. Guérin P, et al. Among authors: pacaud p. J Vasc Res. 2005 Jan-Feb;42(1):21-8. doi: 10.1159/000082873. Epub 2004 Dec 21. J Vasc Res. 2005. PMID: 15627783

10

Synthesis and pharmacological study of Rho-kinase inhibitors: pharmacomodulations on the lead compound Fasudil.

Logé C, Siomboing X, Wallez V, Scalbert E, Bennejean C, Cario-Tourmaniantz C, Loirand G, Gressier B, Pacaud P, Luyckx M. Logé C, et al. Among authors: pacaud p. J Enzyme Inhib Med Chem. 2003 Apr;18(2):127-38. doi: 10.1080/1475636031000093561. J Enzyme Inhib Med Chem. 2003. PMID: 12943196

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page